Skip NavigationSkip to Content
Return Return to Search Results

Antiretroviral Tissue Kinetics: In Vivo Imaging Using Positron Emission Tomography

  1. Author:
    Di Mascio, M.
    Srinivasula, S.
    Bhattacharjee, A.
    Cheng, L.
    Martiniova, L.
    Herscovitch, P.
    Lertora, J.
    Kiesewetter, D.

  2. Author Address

    Di Mascio, Michele] NIAID, Div Clin Res, Biostat Res Branch, NIH, Bethesda, MD 20892 USA. [Srinivasula, Sharat] NCI Frederick, SAIC Frederick Inc, Biostat Res Branch, Frederick, MD 21702 USA. [Bhattacharjee, Abesh, Kiesewetter, Dale] Natl Inst Biomed Imaging & Bioengn, Intramural Res Program, NIH, Bethesda, MD 20892 USA. [Cheng, Lily] NIAID, Div Intramural Res, NIH, Bethesda, MD 20892 USA. [Martiniova, Lucia] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Reprod & Adult Endocrinol Program, NIH, Bethesda, MD 20892 USA. [Herscovitch, Peter] NIH, Warren G Magnuson Clin Ctr, Positron Emiss Tomog Dept, Bethesda, MD 20892 USA. [Lertora, Juan] NIH, Warren G Magnuson Clin Ctr, Clin Pharmacol Program, Bethesda, MD 20892 USA.
    1. Year: 2009
  2. Journal: Antimicrobial Agents and Chemotherapy
    1. 53
    2. 10
    3. Pages: 4086-4095
  4. Type of Article: Article
  1. Abstract:

    Our current knowledge on the antiviral efficacy, dosing, and toxicity of available highly active antiretroviral therapy regimens is mostly derived from plasma or blood kinetics of anti-human immunodeficiency virus (anti-HIV) drugs. However, the blood comprises only 2% of the total target cells in the body. Tissue drug levels may differ substantially from corresponding plasma levels, and drug distribution processes may be characterized by high intertissue variability, leading to suboptimal target site concentrations and the potential risk for therapeutic failures. Positron emission tomography has greatly expanded the scope of the pharmacokinetic measurements that can be performed noninvasively in animal models or humans. We have prepared [F-18]FPMPA, a fluorine-18-radiolabeled analogue of tenofovir, to study antiretroviral tissue kinetics in vivo noninvasively and tested the imaging probe in rats. The biodistribution of the fluorine-18 analogue closely follows that of nonfluorinated tenofovir. Compared to that in the blood, the levels of penetration of the antiretroviral drug were found to be significantly reduced in the spleen and submandibular lymph nodes (similar to 2-fold), in the mesenteric lymph nodes and the testes (similar to 4-fold), and in the brain compartment (similar to 25-fold). Intersubject variability of the trough drug concentration ( measured at 120 min) in certain tissues, like the colon ( coefficient of variation, > 100%), is not reflected by the intersubject variability in the blood compartment ( coefficient of variation, 24%). Positron emission tomography imaging of the fluorine-18 analogue revealed the accumulation of the antiretroviral drug in the cortex of the kidneys, a potential correlate of tenofovir-induced nephrotoxicity observed in HIV-1-infected treated patients. Thus, [F-18]FPMPA is a promising radiotracer for evaluation of tenofovir biodistribution under carefully controlled drug administration protocols.

    See More

  1. Keywords:

External Sources

  1. View Full Text
  2. DOI: 10.1128/aac.00419-09
  3. PMID: 19667288

Library Notes

  1. No notes added.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel